PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Metabolic and Biomolecular Engineering National Research Laboratory, Department of Chemical and Biomolecular Engineering (BK21 four), KAIST Institute for the BioCentury, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Republic of Korea.\', \'Systems Metabolic Engineering and Systems Healthcare Cross-Generation Collaborative Laboratory, KAIST, Daejeon 34141, Republic of Korea.\', \'Zoonotic Virus Laboratory, Institut Pasteur Korea, Seongnam 13488, Republic of Korea.\', \'Zoonotic Virus Laboratory, Institut Pasteur Korea, Seongnam 13488, Republic of Korea; seungtaek.kim@ip-korea.org leesy@kaist.ac.kr.\', \'Metabolic and Biomolecular Engineering National Research Laboratory, Department of Chemical and Biomolecular Engineering (BK21 four), KAIST Institute for the BioCentury, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Republic of Korea; seungtaek.kim@ip-korea.org leesy@kaist.ac.kr.\', \'KAIST Institute for Artificial Intelligence, BioProcess Engineering Research Center, BioInformatics Research Center, KAIST, Daejeon 34141, Republic of Korea.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • e202430211810.1073/pnas.2024302118
?:hasPublicationType
?:journal
  • Proceedings of the National Academy of Sciences of the United States of America
is ?:pmid of
?:pmid
?:pmid
  • 34234012
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 6.092
?:rankingScore_hIndex
  • 675
?:title
  • Drugs repurposed for COVID-19 by virtual screening of 6,218 drugs and cell-based assay.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all